Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth. In the newborn screening, LC-MS/MS method is mainly applied to the detection of amino acids and acyl carnitines in blood.
Tandem mass spectrometry makes it possible to detect extremely low concentrations of compounds that can be used to indicate whether a baby is likely to have an inborn metabolic disorder.
The classification according to the material of Newborn Screening LC-MS Reagent Kit includes Non-derivatized Assay Solutions, Derivatized Assay Solutions, and the proportion of Non-derivatized Assay Solutions in 2017 is about 65.5%.
Newborn Screening LC-MS Reagent Kit is widely used to test Protein Metabolism, Fatty Acid Metabolism, Organic Acid Metabolism, the most proportion of Newborn Screening LC-MS Reagent Kit is used to test Protein Metabolism, and the proportion in 2017 is about 44.2%.
China is the largest sales place, with a sales market share nearly 21.8% in 2017. The demand for Newborn Screening LC-MS Reagent Kit in China is expected to witness growth owing to the increasing of newborn population.
Market Analysis and Insights: Global Newborn Screening LC-MS Reagent Kit Market
The global Newborn Screening LC-MS Reagent Kit market size is projected to reach US$ 265.2 million by 2026, from US$ 212 million in 2020, at a CAGR of 3.8% during 2021-2026.
Global Newborn Screening LC-MS Reagent Kit Scope and Market Size
The global Newborn Screening LC-MS Reagent Kit market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Newborn Screening LC-MS Reagent Kit market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Newborn Screening LC-MS Reagent Kit market is segmented into
Non-derivatized Assay Solutions
Derivatized Assay Solutions
Segment by Application, the Newborn Screening LC-MS Reagent Kit market is segmented into
Protein Metabolism
Fatty Acid Metabolism
Organic Acid Metabolism
The Newborn Screening LC-MS Reagent Kit market is analysed and market size information is provided by regions (countries). Segment by Application, the Newborn Screening LC-MS Reagent Kit market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Newborn Screening LC-MS Reagent Kit market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Newborn Screening LC-MS Reagent Kit business, the date to enter into the Newborn Screening LC-MS Reagent Kit market, Newborn Screening LC-MS Reagent Kit product introduction, recent developments, etc.
The major vendors covered:
Perkinelmer
Danaher
Chromsystems
Zivak Technologies
Trivitron (Labsystems)
BGI
Tandem mass spectrometry makes it possible to detect extremely low concentrations of compounds that can be used to indicate whether a baby is likely to have an inborn metabolic disorder.
The classification according to the material of Newborn Screening LC-MS Reagent Kit includes Non-derivatized Assay Solutions, Derivatized Assay Solutions, and the proportion of Non-derivatized Assay Solutions in 2017 is about 65.5%.
Newborn Screening LC-MS Reagent Kit is widely used to test Protein Metabolism, Fatty Acid Metabolism, Organic Acid Metabolism, the most proportion of Newborn Screening LC-MS Reagent Kit is used to test Protein Metabolism, and the proportion in 2017 is about 44.2%.
China is the largest sales place, with a sales market share nearly 21.8% in 2017. The demand for Newborn Screening LC-MS Reagent Kit in China is expected to witness growth owing to the increasing of newborn population.
Market Analysis and Insights: Global Newborn Screening LC-MS Reagent Kit Market
The global Newborn Screening LC-MS Reagent Kit market size is projected to reach US$ 265.2 million by 2026, from US$ 212 million in 2020, at a CAGR of 3.8% during 2021-2026.
Global Newborn Screening LC-MS Reagent Kit Scope and Market Size
The global Newborn Screening LC-MS Reagent Kit market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Newborn Screening LC-MS Reagent Kit market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Newborn Screening LC-MS Reagent Kit market is segmented into
Non-derivatized Assay Solutions
Derivatized Assay Solutions
Segment by Application, the Newborn Screening LC-MS Reagent Kit market is segmented into
Protein Metabolism
Fatty Acid Metabolism
Organic Acid Metabolism
The Newborn Screening LC-MS Reagent Kit market is analysed and market size information is provided by regions (countries). Segment by Application, the Newborn Screening LC-MS Reagent Kit market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape
and Newborn Screening LC-MS Reagent Kit Market Share AnalysisNewborn Screening LC-MS Reagent Kit market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Newborn Screening LC-MS Reagent Kit business, the date to enter into the Newborn Screening LC-MS Reagent Kit market, Newborn Screening LC-MS Reagent Kit product introduction, recent developments, etc.
The major vendors covered:
Perkinelmer
Danaher
Chromsystems
Zivak Technologies
Trivitron (Labsystems)
BGI
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
